In the past year, Huaxia Military Industrial Company has basically not performed particularly well. As the president, Yao Ziliang has made very few reports at meetings.
Due to the implementation of Zhao Yitao's strategy of biding his time, although Huaxia Military Industrial Company has very advanced design capabilities, as well as strong manufacturing capabilities given by Precision Instrument Company and Cornerstone Materials Company.
But so far, no physical piece of military equipment has been manufactured. The R&D personnel in the company are still quietly carrying out design work, hoping to design military equipment even better.
According to Zhao Yi's plan, even if the relevant physical military equipment is manufactured, it will be on par with the world's advanced equipment and does not need to be too advanced.
However, due to the advanced materials, manufacturing processes and equipment of these military equipment, coupled with the advanced design concepts provided by Zhao Yi, it is not difficult for Huaxia Military Industrial Company.
In fact, they have completed all the design work, and even the subsequent manufacturing has been deduced. After finding that there are no problems, they continue to research the next generation of military equipment that is more advanced than today.
As the president, Yao Ziliang only introduced to Zhao Yi the company's current R&D personnel and the ongoing research on leading-generation military equipment at the meeting.
It can be said that the next generation of military equipment and land equipment will not have earth-shaking changes in the upgrade effect. The data will be further improved in various indicators, and there will not be a big span.
But in terms of flight equipment, there is indeed a huge difference. According to Zhao Yi's instructions, in the next generation of equipment, more emphasis will be placed on stealth performance and long-range strike capabilities, to pre-emptively defend the enemy thousands of miles away.
At the same time, great breakthroughs must be made in high-speed cruising, and intelligent command systems must be integrated into aviation equipment to emphasize intelligent control and further improve the advantages in air combat.
Yao Ziliang also knew that his boss was knowledgeable, so at the meeting, they discussed the design of the equipment in great detail, and finally gained something.
After thinking for a while, Zhao Yi decided to let Huaxia Military Industrial Company start manufacturing some equipment, especially the manufacturing of naval and air force military equipment. It needs to start taking action now.
It is now 1986, and it has only been a few years since the international situation changed dramatically. Once Yingjiang feels that the polar bears are no longer a threat to him, or thinks that he can solve it alone, the honeymoon period between the two countries is over.
Before that, the country needs to accumulate enough military force to defend its own interests, so that others who want to make some careful decisions must also think twice.
Military equipment is not just manufactured and can be used immediately on the battlefield, but requires soldiers to run in for a period of time, especially aviation military equipment and naval military equipment.
Therefore, Zhao Yi asked Yao Ziliang at the meeting to start planned production of the advanced military equipment that had been designed in the new year.
Due to the strict requirements of military equipment, the production speed will certainly not be particularly fast. This year, it will mainly focus on trial production, physical testing, and efforts to obtain orders from the Ministry of National Defense.
After this step is basically completed, you can start to consider expanding production and increasing production capacity. You cannot blindly expand production because of confidence, otherwise, you may only suffer the loss.
Although this probability may be very low, as a business operator, it is impossible not to consider this situation. Once something unexpected occurs, it is likely to cause the company to fall into losses immediately.
You must know that our country still focuses on economic development and has not invested a lot of financial support in the military industry. National defense is still focused on defense.
In this context, although Huaxia Military Industrial Company owns advanced military equipment, the number of orders may not be large, especially early orders, and there will not be many.
Because the international situation will not change significantly after these military equipment are produced, the necessity of large-scale updates of new equipment may be discussed by relevant parties.
You know, the price of military equipment is quite expensive. As a private military equipment research and manufacturing company, it is impossible to just maintain capital operations, and they are not a state-owned enterprise.
Even though Zhao Yi has a patriotic heart, the sales price is based on the market price, which may be superior to the military equipment of other countries in terms of advanced level.
Due to concerns about the purchase quantity, Huaxia Military Industrial Company still needs to be cautious about expanding production. In the end, it is better to decide based on the order quantity, rather than blindly expanding production.
To be honest, it is estimated that it is difficult to support Huaxia Military Industrial Company solely relying on domestic orders. Even if it can be supported, it will still be half-dead. It is basically impossible to make a lot of money.
So Zhao Yi asked Yao Ziliang to start researching the foreign trade version of military equipment at the meeting. According to Zhao Yi's instructions, the foreign trade version of military equipment only needs to meet the performance of international mainstream military equipment.
There is absolutely no need to export military equipment that is more advanced than today's mainstream military equipment. Only in this case will military imbalances not occur. Under this premise, of course, the more military equipment the better.
After finishing the meeting with Yao Ziliang, Zhao Yi thought for a while and decided that he would first communicate with the military personnel to let them understand the current research progress of China Military Industrial Company.
As long as it is approved by them, subsequent manufacturing, aerial testing, and perhaps procurement will be greatly facilitated, and obstacles and difficulties encountered will be reduced.
Especially naval ship equipment, because the manufacturing time is very long, the design plan must be approved by the military before it can be manufactured. Otherwise, after one ship is manufactured, it will be a long test, which takes too much time.
If approval can be obtained at the design stage, with Zhao Yi's own confidence, several ships of the same model and equipment can be built at the same time.
At present, Zhao Yi will not proceed with the construction of aircraft carriers. Now he is mainly consolidating the foundation of other ships surrounding the aircraft carrier. After these peripheral ships reach a certain number, the aircraft carrier can be formed into a formation as soon as it is built.
Of course, this is also related to the current national defense policy. There is not much temporary demand for aircraft carriers with very strong offensive capabilities. These things will only be of great use when their overseas interests are seriously threatened.
China Medical Company spent a lot of energy on Zhao Yi a while ago, because it is so important, and it is a very important part of Zhao Yi's domestic welfare contracting work.
Fortunately, all aspects cooperated very smoothly, so that China Medical Company not only did not have internal chaos problems, but also was able to achieve the service quality expected by Zhao Yi.
According to a report by its president Zheng Xiyao, two months have passed and China Medical Company’s domestic medical services are on track.
Judging from the current investigations and complaints, the business is running very smoothly, and people all over the country can receive free medical treatment immediately, and there are no long queues.
Hearing this, Zhao Yi affirmed Zheng Xiyao's efforts during this period at the meeting, and asked him to distribute the rewards in a timely and effective manner to express condolences to all medical workers during this period. time of hard work.
Compared with domestic business, what surprises Zhao Yi even more is that in the past two months, the number of overseas patients coming to China for medical treatment has shown a rapid increase trend.
Although from a humanitarian perspective, Zhao Yi should not be optimistic and happy about this, but as a businessman, it is indeed a very happy thing.
In the past two months, Chinese medical companies have received a total of 2 million patients in China. Most of the patients who are so eager to come to China for treatment are severe patients.
Because they did not have much time to waste, many of them began to carry out self-rescue operations after learning that Chinese medical companies could treat many terminal diseases.
Fortunately, the travel agency under the trading company plays an important role. The full nanny-style arrangement brings great convenience to seriously ill patients coming to China. Of course, the service fee is not very low.
The average medical expenses for these more than 2 million severe patients have reached about 150,000 yuan. In other words, in just these two months, Chinese medical companies have achieved more than 300 billion yuan in operating income from overseas patients.
Of course, the bulk of this is still taken away by Chinese pharmaceutical companies. After all, special drugs are produced by Chinese pharmaceutical companies. Without these special drugs, it would be difficult for Chinese medical companies to achieve this kind of therapeutic effect.
According to statistics from China Medical Corporation, Chinese pharmaceutical companies account for 70% of this revenue, while China Medical Corporation worked hard and only received the remaining 30%.
Although if you look at it this way, the benefits should be guaranteed, but in fact this is not the case, because the specific drugs of Chinese pharmaceutical companies can be very effective in treating difficult and complicated diseases, so that Chinese medical companies do not pay too much cost.
Therefore, in just two months, Chinese medical companies have been able to obtain more than 90 billion yuan in additional revenue, which is very happy. Calculated on this scale, the revenue this year is very considerable.
Like Maria, the Swedish journalist I wrote about before, when she came to see a doctor, the Chinese medical company just gave her a full body examination, and then gave her three kinds of special medicines, followed by observation. After the observation period, the disease was cured. .
Among them, Chinese medical companies did not put in much effort, and the personnel investment cost was not very large. This is the fundamental reason why Chinese medical companies were able to receive more than 2 million patients in just two months.
If it is true that every patient requires doctors to spend too much energy on treatment, then the scale of medical staff in foreign-related hospitals simply cannot handle so many patients.
From this perspective, it is not surprising that Chinese pharmaceutical companies get the majority of the profits. In the final analysis, the reason why Chinese medical companies can obtain such huge benefits is basically relying on the scientific and technological achievements of Chinese pharmaceutical companies.
But compared with the money that Chinese medical companies make from patients coming to China, their domestic business is at a huge loss. You know, although Chinese pharmaceutical companies provide domestic patients with some discounts, they are not very large.
For specific drugs for difficult and complicated diseases, the price that Chinese pharmaceutical companies offer to domestic patients is only 10% off the price they offer to foreign patients, which is not a lot of profit.
The reason why they do this is to prepare for their internationalization. If they just want to develop domestic business, then it doesn't matter how much they pay. After all, they are all the same boss, and the left hand is the right hand.
But if they are internationalized, their medicines and equipment products will be sold abroad. If they are sold domestically too cheaply, it will give other countries a bad impression and make them feel that they have been taken advantage of.
But if it is the same at home and abroad, even if it is too expensive to buy abroad, they will not be able to say anything. Chinese pharmaceutical companies can definitely say that this is market pricing and there is no human control at all.
Therefore, in just the past two months, Chinese medical companies have lost 200 billion yuan in domestic business. This is because Chinese medical companies have many advanced treatment options and have reduced costs.
If we continue to use high-priced special drugs from Chinese pharmaceutical companies for treatment, it is estimated that we will not be able to stop the loss of 500 billion yuan. After all, the seriously ill patients who have accumulated in the country for so many years are concentrated in seeking medical treatment during this period.
It can be seen from this that Chinese medical companies actually have many advanced treatment options that do not require the use of particularly expensive specific drugs, but this low-cost treatment option takes a long time.
The reason why they treat Chinese and foreign patients differently is because of cost considerations. Domestic medical costs must be borne entirely by Chinese medical companies themselves. Of course, they can reduce costs if they can, as long as they can cure the patient's disease.
Only for diseases that cannot be treated through medical treatment, Chinese medical companies will consider using special drugs from Chinese pharmaceutical companies. Zhao Yi didn't say anything about this. Anyway, it's a matter of left hand and right hand.
And this is what Zhao Yi requested, because if Chinese medical companies rely entirely on the drugs of Chinese pharmaceutical companies in the treatment process, then their medical skills are likely to deteriorate over time.
From now on, everyone will no longer study how to treat diseases, but will wait for Chinese pharmaceutical companies to develop specific drugs.
So if a very difficult new disease emerges and Zhao Yi is not available to participate, Chinese pharmaceutical companies will not be able to develop specific drugs in a short period of time. What should Chinese medical companies do
So Zhao Yi is very concerned about this, because he can't always be a nanny to protect them. Many thorny problems in the future will need to be solved by themselves.
In addition, Zhao Yi had left them many advanced treatment plans before. It would be a bit unreasonable for them to not make progress and work hard to improve their medical skills under such circumstances.
But the situation is different for foreign patients. In addition to providing better medical environments to foreign-related hospitals, Chinese medical companies actually have relatively few medical resources.
You must know that our country's medical resources are in short supply. How can we give more medical resources to foreign-related hospitals? In this case, we can only use special drugs, which saves time and effort. How good.
Anyway, Chinese medical companies do not need to bear this part of the cost. Foreign patients who can come to China for medical treatment so quickly are at least middle class or above in their countries. If they don't make money from them, who else will make money.
Most of this money flows into the hands of Chinese pharmaceutical companies. The true cost of these special drugs is very low. Chinese pharmaceutical companies can earn a lot of profits, and these profits eventually return to the hands of the same boss.
Then the boss subsidizes a large amount of profits earned by Chinese pharmaceutical companies to Chinese medical companies. In this cycle, all stakeholders in the chain do not suffer.
Therefore, when calculating the income of Chinese pharmaceutical companies, it is necessary to first deduct the losses of Chinese medical companies, because the hole in the losses of Chinese medical companies will eventually need to be made up by Chinese pharmaceutical companies.
The rest is where Chinese pharmaceutical companies can create value for Zhao Yi. According to the current situation, the main source of revenue for Chinese pharmaceutical companies is these overseas patients in China.
If things continue like these two months in the future, then within this year, these overseas patients can jointly create 1.8 trillion yuan in revenue for Chinese pharmaceutical companies and Chinese medical companies.
If the profits and losses of the two companies are calculated together, Zhao Yi does not need to subsidize it himself, and may even make a fortune from this.
However, Zhao Yi feels that the good times of Chinese medical companies may not last long, and foreign medical institutions are not fools. Will they allow them to make such huge profits? Absolutely not.
But do they have the ability to treat these diseases? What should they do
The only solution is to speed up the overseas clinical trials and approvals of Chinese pharmaceutical companies' drugs. As long as drugs that have been successfully verified domestically are allowed to enter their countries, these patients will not need to come to China for treatment.
Of course, this will harm the interests of international pharmaceutical giants. After all, compared to curing other people's diseases, many of their drugs can only delay time. The interests here are even more ruthless than those of Chinese pharmaceutical companies.
By then, foreign medical institutions and pharmaceutical companies may have irreconcilable conflicts, because at this time, their interests will be inconsistent, and Chinese pharmaceutical companies will become important partners of these medical institutions.
Unless they both join forces to block patients coming to China for treatment, or discredit Chinese medical companies, spreading rumors that Chinese medical companies do not have miraculous medical skills as advertised.
In order to avoid trouble in this regard, when foreign-related hospitals of Chinese medical companies receive patients, they will sign a liability exemption agreement with the patients.
In this exemption agreement, the foreign-related hospitals of Chinese medical companies bear medical responsibility for the treatment of patients during their treatment in the hospital, but they do not assume any medical responsibility after discharge.
In other words, foreign-related hospitals are only responsible for the responsibilities during the hospital treatment, and are not responsible for any responsibilities after discharge. They are afraid that these patients will be bewitched by the above two interest groups, spread rumors against Chinese medical companies, and even make claims.
Chinese medical companies are too lazy to deal with people like them. A direct exemption agreement interrupts these people's attempts. However, the smear campaign will not be completely eliminated. Chinese medical companies have long been mentally prepared for this.
Where there are people, there are rivers and lakes, and where there are rivers and lakes, good and evil are sometimes not so clear-cut, so Chinese medical companies entrust Yuheng Law Firm to fully represent global legal issues.
Although Yuheng Law Firm is not well-known and appears in the book just for playing a soy sauce role, after years of global layout, they have invested in and cooperated with law firms all over the world, and their influence is actually very great.
This is why over the years, when Zhao Yi's companies have been wildly developing around the world, nothing particularly regrettable has happened to them. In this, Yuheng Law Firm has played a decisive role. (End of chapter)